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Cerebellar dysplasia with cysts (CDC) is an imaging finding typically seen in combination with cobblestone cortex and congenital
muscular dystrophy in individuals with dystroglycanopathies. More recently, CDC was reported in seven children without neuromus-
cular involvement (Poretti-Boltshauser syndrome). Using a combination of homozygosity mapping and whole-exome sequencing, we
identified biallelic mutations in LAMA1 as the cause of CDC in seven affected individuals (from five families) independent from those
included in the phenotypic description of Poretti-Boltshauser syndrome. Most of these individuals also have high myopia, and some
have retinal dystrophy and patchy increased T2-weighted fluid-attenuated inversion recovery (T2/FLAIR) signal in cortical white matter.
In one additional family, we identified two siblings who have truncating LAMA1mutations in combination with retinal dystrophy and
mild cerebellar dysplasia without cysts, indicating that cysts are not an obligate feature associated with loss of LAMA1 function. This
work expands the phenotypic spectrum associated with the lamininopathy disorders and highlights the tissue-specific roles played
by different laminin-encoding genes.Cerebellar dysplasia is a neuroimaging finding that de-
scribes abnormalities of both the cerebellar cortex and
white matter and is associated with variable neurodevelop-
mental outcome.1–4 Cerebellar dysplasia is presumed to
arise through genetic or acquired developmental defects
that affect cerebellar foliation and fissure formation.5
Although in most cases the etiology of generalized cere-
bellar hemisphere dysplasia is unknown, this imaging
finding has been reported in congenital muscular dystro-
phies (CMDs), most notably POMGNT1-related CMD
(MIM 606822),6 and in Chudley-McCullough syndrome
(MIM 604213). Although generally rare, cerebellar cysts
are frequently identified in individuals with CMD.6
Recently, a distinctive cerebellar dysplasia with cysts
(CDC) phenotype was described in seven children (from
five families) with ataxia, intellectual disability, and lan-
guage impairment but without significant muscle disease
(Poretti-Boltshauser syndrome).7 Although the nine genes
in which loss-of-function mutations have been shown to
cause CMD (POMT1 [MIM 607423], POMT2 [MIM
607439], POMGNT1, FKRP [MIM 606596], FKTN [MIM
607440], LARGE [MIM 603590], ISPD [MIM 614631],
B3GALNT2 [MIM 610194], and GPR56 [MIM 604110])
were sequenced in these seven children, the genetic cause
of CDC was not identified. Here, we report that mutations
in LAMA1 (MIM 150320; RefSeq accession number
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The AmerCDC, and we expand the phenotype to include milder
brain-imaging findings and retinal dystrophy.
Initially, we enrolled a series of three CDC-affected in-
dividuals from three families under informed consent
through human-subjects-research protocols approved by
the institutional review boards at the University of Wash-
ington and the University of Calgary. The phenotype of
these individuals is indistinguishable from that described
in Poretti-Boltshauser syndrome.7 To identify the genetic
cause of CDC in these individuals, we combined homozy-
gosity mapping and exome sequencing. Genome-wide
SNP genotyping was performed with the Affymetrix
Genome-wide Human SNP Array 6.0 on peripheral-blood
DNA from CA0035 (II-3 in Figure 1B), whose parents
are first cousins. Using HomozygosityMapper,8 we iden-
tified ten copy-number-neutral homozygosity regions
(Figure 1A) spanning >10 Mb, including a 15.9 Mb stretch
in chromosomal region 18p11.31–p11.2 between markers
rs1940954 and rs2850205.
We then performed whole-exome sequencing on periph-
eral-blood DNA from all three individuals (Table S1, avail-
able online), as described previously.9 In brief, genomic
DNA was captured with the Agilent SureSelect v.5 exome
capture oligonucleotide library and sequenced with
paired-end 100 bp reads on Illumina HiSeq 2000. TTN
(MIM 188840) and LAMA1 were the only genes found to
harbor rare (<5% in 1000 Genomes), deleterious variants2Seattle Children’s Research Institute, Seattle, WA 98101, USA; 3Department
d and Maternal Health, University of Calgary, Calgary, AB T3B 6A8, Canada;
A 1A4, Canada; 5Department of Radiology, Seattle Children’s Hospital, Seat-
ch Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada; 7Division
e, WI 53201, USA; 8Division of Medical Genetics, Nemours/Alfred I. duPont
, Madigan Army Medical Center, Tacoma, WA 98431, USA; 10Department of
.edu (D.D.)
y of Human Genetics. All rights reserved.
ican Journal of Human Genetics 95, 227–234, August 7, 2014 227
LAMA1
c.8557-1C>G
c.7965-15_9765-3del
c.6701delC
c.6345+3G>C
c.2986delA
c.2816_2817delAT
c.768+1G>A
c.588+2T>G
c.555T>G
A B
C
c.588+2T>G/
CA0035
c.588+2T>G
c.768+1G>A
UW160
c.6701delC
c.8557-1G>C
c.768+1G>A
c.6701delC
c.8557-1G>C
c.6701delC
c.768+1G>A/
c.8557-1G>C
c.2986delA/
c.7965-15_7965-3del
UW162
c.555T>G/
c.2816_2817delAT
UW163
c.555T>G/
c.2816_2817delAT
c.2816_2817delAT c.555T>G
c.6345+3G>C/
UW154
Exon 4-11
deletion
Exon 4-11
deletion
c.6345+3G>C
1 2
3
1 2
3
1 2
3
1 2 1 2
3 4 3 4
D
4443 45 46
No mutation
Splice mutation
L C1 C2 P C1 C2 P 
170 bp 
199 bp 
354 bp 43 44 45 46 
43 45 46 
44 45 
Exons 44-45 Exons 43-46
I
II
I
II
I
II
I
II
I
II
Figure 1. Mutation Identification in Individuals with CDC
(A) Homozygosity mapping in CA0035 identified several regions of homozygosity (red) across the genome. Homozygous regions
on chromosome 18 are indicated below the genome-wide mapping. An arrowhead below the chromosome 18 ideogram indicates the
location of LAMA1.
(B) Pedigree diagrams showing segregation analysis for five families.
(C) LAMA1 is composed of 63 exons that span chr18: 6,941,743–7,117,813 (UCSC Genome Browser hg19) and encode protein-coding
sequence. Arrows indicate the locations of ten different mutations identified in five families. The horizontal red bar represents a deletion
spanning LAMA1 exons 4–11.
(D) The splice-site mutation (designated red in C) in UW154-3 results in skipping of exon 45. Total RNA was isolated from fibroblasts
with the RNeasy Mini Kit (QIAGEN) and transcribed into cDNA with the SuperScript III First-Strand System and random hexamer
primers (LifeTechnologies). RT-PCR was performed under standard conditions with forward primers in exons 43 and 44 and reverse
primers in exons 45 and 46 (sequences are available upon request). Primers in exons 44 and 45 generated a 170 bp amplicon in
cDNA from two unrelated, unaffected control fibroblasts but minimal product in cDNA from UW154-3. Primers in exons 43 and 46
generated a 354 bp amplicon in control cells and a 199 bp product in UW154-3. Sanger sequencing of this product revealed that
exon 43 is spliced to exon 45 in UW154-3 (data not shown). The horizontal arrows indicate primer positions. The red arrow indicates
the location of the splice-site mutation in intron 44. ‘‘L’’ indicates the ladder lane, ‘‘C1’’ and ‘‘C2’’ indicate the two control samples,
and ‘‘P’’ indicates individual UW154-3. The expected size and exon composition of the respective products are indicated to the right
of the gel.in all affected individuals and lie within homozygous
regions identified in CA0035 (Table S2 and Figure 1A).
BecauseTTN is a very large gene that frequentlyharbors var-
iants mainly as a result of its large size, and no individuals
with CDC have the dilated or hypertrophic cardiomyopa-
thy that has been associated with TTN mutations, it was
excluded from consideration. The LAMA1 variants are not
present in 1000 Genomes, the NHLBI Exome Sequencing
Project Exome Variant Server (EVS), dbSNP version 137, or
an in-house exome database consisting of ~2,000 samples
and are predicted to truncate the protein or result in aber-
rant splicing by Human Splicing Finder v.3.0.10 CA0035228 The American Journal of Human Genetics 95, 227–234, August 7carries a homozygous canonical splice variant in the donor
site for exon 5 of LAMA1 (c.588þ2T>G). UW162-3 (II-3
in Figure 1B) carries a heterozygous 13 bp deletion
(c.796515_79653del) that is predicted to alter splicing
and a heterozygous 1 bp deletion (c.2988_2989delA) that
is predicted to cause a frameshift and premature truncation
of the protein (p.Thr996Hisfs28*). UW154-3 (II-3 in
Figure 1B) carries a single heterozygous variant at the third
nucleotide of the splice donor site in intron 44 of LAMA1
(c.6345þ3G>C). This mutation results in a transcript that
is missing exon 45 (Figure 1D) and is predicted to generate
a truncated protein (p.Thr2064Ansfs*2). These variants, 2014
were confirmed by Sanger sequencing and segregated
appropriately in the families (Figure 1B and Figure S1).
Because we identified only a single LAMA1 variant in
UW154-3, we hypothesized that a heterozygous deletion
in LAMA1 might be present. We used the whole-exome
sequencing data to analyze copy-number variants (CNVs)
with FishingCNV.11 To identify rare CNVs, we used the
same exome sequencing protocol to compare the read
depth of the variants in UW154-3 against the distribu-
tion of reads in more than 50 control individuals with
unrelated genetic disorders. This analysis identified a sig-
nificant heterozygous LAMA1 deletion variant (p ¼
4.98 3 1045) spanning exons 4–11 (chr18: 7,038,808–
7,050,935, hg19). There is a long tandem repeat (L1MA9)
on the centromeric side, but not on the telomeric side, of
this CNV. No deletion at this position has been reported
in the Database of Genomic Variants.12 Quantitative PCR
confirmed the deletion and found that it was paternally in-
herited (Figure S2).
In parallel, we performed exome sequencing in a cohort
of 40 individuals with a clinical diagnosis of Joubert syn-
drome (MIM 213300) and in whom targeted sequencing
had excluded mutations in all published genes implicated
in Joubert and Meckel syndromes (NPHP1 [MIM 607100],
AHI1 [MIM 608894], CEP290 [MIM 610142], RPGRIP1L
[MIM 610937], TMEM67 [MIM 609884], CC2D2A [MIM
612013], ARL13B [MIM 608922], INPP5E [MIM 613037],
OFD1 [MIM 300170], TMEM216 [MIM 613277], CEP41
[MIM 610523], TMEM237 [MIM 614423], TCTN2 [MIM
613846], KIF7 [MIM 611254], TCTN1 [MIM 609863],
TMEM138 [MIM 614459], MKS1 [MIM 609883], C5ORF42
[MIM 614571], TMEM231 [MIM 614949], TCTN3 [MIM
613847], CSPP1 [MIM 611654], PDE6D [MIM 602676],
IFT172 [MIM 607386], ZNF423 [MIM 604557], TTC21B
[MIM 612014], B9D1 [MIM 614144], and B9D2 [MIM
611951]). Joubert syndrome is a recessive neurodevelop-
mental disorder typically defined by a pathognomonic
brainmalformation: ‘‘themolar-tooth sign,’’ which consists
of cerebellar vermis hypoplasia, thickened, horizontally ori-
ented superior cerebellar peduncles, and sometimes a deep
interpeduncular fossa.13 CDC and Joubert syndrome share
nonspecific clinical features, including cognitive impair-
ment, hypotonia, ataxia, and abnormal eye movements,
but CDC does not manifest with the alternating tachypnea
and apnea often seen in Joubert syndrome. Some individ-
uals with Joubert syndrome also develop progressive retinal
dystrophy, cystic kidney disease, and/or liver fibrosis that
result in significant morbidity and mortality. Surprisingly,
exome sequencing in one of the families previously diag-
nosed with Joubert syndrome revealed in one affected sib-
ling (UW160-3 [II-3 in Figure 1B]) four rare LAMA1 variants,
three of which were maternally inherited (c.8557–1G>C
[in 0/13,006 EVS chromosomes], c.2657C>T [p.Ala886Val]
[in 34/13,006 EVS chromosomes, PolyPhen-2 scores
0.907 and 0.753], and c.768þ1G>A [in 0/13,006 EVS
chromosomes]) and one of which was paternally inher-
ited (c.6701delC [p.Pro2334Leufs9*]). Sanger sequencingThe Amerconfirmed that the other affected sibling (UW160-4 [II-4
in Figure 1B]) also carries all four variants. In a second fam-
ily with two siblings (UW163-3 and UW163-4) previously
diagnosed with mild Joubert syndrome, we identified com-
pound-heterozygous mutations (the paternally inherited
c.2816_2817delAT [p.Tyr939Leufs27*] and the maternally
inherited c.555T>G [p.Tyr185*] [in 0/13,006 EVS chromo-
somes]) in LAMA1 in UW163-3. Sanger sequencing
confirmed that the other affected sibling (UW163-4) shares
these variants in LAMA1.
We reviewed the clinical and imaging features for the
affected individuals from all five families (Table 1). Four in-
dividuals showed classic CDC findings, including cere-
bellar dysplasia with cysts (more severe rostrally and
ventrally) and cerebellar vermis hypoplasia. In three, the
superior cerebellar peduncles were elevated and splayed,
and the fourth ventricle was elongated rostrocaudally
and laterally (Figure 2). Minor abnormalities of the brain-
stem included a short pons (CA0035 and UW154-3), nar-
row isthmus (UW154-3 and UW160-4), and longmidbrain
(UW154-3). Although UW160-4 had somewhat long supe-
rior cerebellar peduncles, they were not classic for the
molar-tooth appearance that defines Joubert syndrome.13
Similarly, UW163-3 and UW163-4 were previously catego-
rized as having mild Joubert syndrome without the classic
molar-tooth sign. A few supratentorial abnormalities pre-
sent on imaging included a single periventricular heteroto-
pia in CA0035 (Figure 2E), partial agenesis of the corpus
callosum (a missing rostrum and a markedly thin isthmus
and splenium) and partial absence of the septum pelluci-
dum in UW154-3 (Figures 2I and 2J), and patchy increased
T2-weighted fluid-attenuated inversion recovery (T2/
FLAIR) in CA0035 and UW154-3 (Figures 2E and 2J).
Notably, four affected individuals had large eye globes,
consistent with high myopia (>6 diopters). In contrast,
UW163-3 and UW163-4 had superior cerebellar dysplasia
without cysts (Figure 2L) and mild vermis hypoplasia
(Figure 2N). UW163-3 also had patchy increased T2/FLAIR
(Figure 2O) and a suprasellar arachnoid cyst, whereas
UW163-4 had slightly elevated superior cerebellar pedun-
cles and large globes (data not shown).
All seven affected individuals had a history of motor
delay, three had speech delay, and one was diagnosed
with Asperger syndrome, but one was able to graduate
from college and live independently as an adult (Table 2).
All individuals also had abnormal eye movements, myopia
(five with high myopia), and retinal differences, including
thinning (UW154-3), atrophy (CA0035 and UW160-4), ab-
sent pigment (UW162-3), and overt early-onset retinal dys-
trophy with visual impairment (UW160-3) and abnormal
electroretinography (ERG) (UW163-3 and UW163-4).
UW160-3 also had macular heterotopia, and UW160-4
had bilateral cataracts noted at 22 years of age. Creatine
kinase levels were not substantially elevated in three indi-
viduals, and no other clinical features were observed in
more than one individual. The individuals previously
diagnosed with Joubert syndrome did not display evidenceican Journal of Human Genetics 95, 227–234, August 7, 2014 229
Table 1. Brain MRI Features in Affected Individuals with LAMA1 Mutations
CA0035 UW154-3 UW162-3 UW160-4 UW163-3 UW163-4
cDNA mutation 1 c.588þ2T>G c.6345þ3G>C
(maternal)
c.796515_79653del
(paternal)
c.6701delC
(paternal)
c.2816_2817delAT
(paternal)
c.2816_2817delAT
(paternal)
Protein alteration 1 canonical splice splice splice p.Pro2334Leufs9* p.Tyr939Leufs27* p.Tyr939Leufs27*
cDNA mutation 2 c.588þ2T>G deletion of exons
4–11 (paternal)
c.2988_2989delA
(maternal)
c.85571G>C,
c.768þ1G>A
(maternal)
c.555T>G
(maternal)
c.555T>G
(maternal)
Protein alteration 2 canonical splice NA p.Pro996Hisfs28* splice, splice p.Tyr185* p.Thr185*
Age at MRI 8 months 5 and 15 months 9 months unknown 25 months 5 months
Cerebellar dysplasia yes yes yes yes superior only superior only
Cerebellar cysts yes yes yes yes no no
Vermis hypoplasia global global global global inferior only inferior only
SCPs elevated and
splayed
elevated and splayed normal elevated and
splayed
normal slightly elevated
Fourth ventricle enlarged enlarged enlarged enlarged mildly enlarged normal
Brainstem short pons,
thin isthmus
short pons, long
midbrain, mildly
enlarged tectum
normal thin isthmus mass effect from
arachnoid cyst
normal
Ventricles normal moderate VM, partial
agenesis of CC and SP
normal normal normal normal
Eyes large large large large normal large
Increased T2/FLAIR
in white matter
patchy increased,
periventricular
patchy increased,
periventricular
normal normal patchy increased,
periventricular
normal
Other heterotopia in
right lateral
ventricle
NA NA NA suprasellar and
interpeduncular
cyst
NA
Abbreviations are as follows: CC, corpus callosum; NA, not applicable; SCP, superior cerebellar peduncle; SP, septum pellucidum; and VM, ventricuolmegaly.of cystic kidney disease, liver fibrosis, polydactyly, colo-
boma, or other clinical features associated with Joubert
syndrome.
LAMA1-related CDC contributes to the growing list of
phenotypes associated with loss of function of laminin-
encoding genes. An overlapping spectrum of posterior
predominant brain phenotypes are characteristic of muta-
tions in LAMA2 (MIM 156225), LAMB1 (MIM 150240),
LAMC1 (MIM 150290), and LAMC3 (MIM 604349) and
range from occipital cortical defects to Dandy-Walker
malformation.14–17 Recessive LAMA2 mutations are the
primary cause of CMD with occasional occipital polymi-
crogyria and epilepsy as a result of a complete lack of
merosin, a component of the skeletal-muscle extracellular
matrix protein laminin-2.17 Recessive mutations in LAMB1
and LAMC3 each cause occipital cobblestone malforma-
tion, whereas mutations in LAMB1 additionally cause cere-
bellar vermis and brain stem hypoplasia with variable
ocular defects and occasional occipital cephalocele.14,16
Heterozygous LAMC1mutations cause Dandy-Walker mal-
formation and occipital cephalocele.15 Strikingly, none of
these phenotypes includes the cerebellar cysts that are
prominent in individuals with LAMA1 mutations.
Laminins are extracellular matrix proteins required for
basementmembrane assembly and critical for early embry-230 The American Journal of Human Genetics 95, 227–234, August 7onic development.18 In mice, LAMA1 localizes exclu-
sively in basement membranes, including within the
mesenchyme adjacent to the developing cerebellum.19
Mice with homozygous knockout of Lama1 die in the
early embryonic period as a result of impaired epiblast
differentiation.20 However, Lama1-conditional-knockout
mice that overcome this early lethality have motor and co-
ordination deficits and an overproliferation of granule cell
precursors and subsequent excessive cell death, leading to
mislocalization of granule cells and an overall reduced size
of the adult cerebellum.21,22 In addition, the eye pheno-
types described in mouse and zebrafish models parallel
the findings described in our cohort. Hypomorphic and
null Lama1 mutations in mice cause defects in the retinal
inner limiting membrane, attenuated ERG, abnormal
retinal vasculature, and progressive cell loss from the inner
nuclear and ganglion cell layers.23,24 Zebrafish lama1-
mutant larvae exhibit attenuated ERG, lens and vascula-
ture abnormalities, shortened and ectopic photoreceptor
cells, and axon-guidance defects, whereas adult zebrafish
mosaic for lama1 mutations exhibit cataracts, similar to
the cataracts in UW160-4.25,26 Further evaluation of the
eye findings in individuals with LAMA1 mutations could
reveal a distinctive phenotype that will be helpful for diag-
nosis in the future. Intriguingly, LAMA1 has also been, 2014
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Figure 2. Brain and Eye Imaging Findings in Affected Individuals with LAMA1 Mutations
(A–E) Individual CA0035 has cerebellar cysts (arrowheads in A), superior cerebellar dysplasia (arrow in B) and large globes (B), elevated
and splayed superior cerebellar peduncles (arrowheads in C), an enlarged fourth ventricle (A and D), and patchy increased T2/FLAIR
(asterisks in E). The periventricular heterotopia (arrowhead in E) is atypical.
(F–J) Similar findings in UW154-3 include cerebellar cysts (arrowhead in F), superior cerebellar dysplasia (arrowhead in G) and large
globes (G), elevated and splayed superior cerebellar peduncles (arrowheads in H), an enlarged fourth ventricle (F and I), and patchy
increased T2/FLAIR (asterisks in E). In addition, UW154-3 has partial absence of the corpus callosum (bracket in I) and septum pelluci-
dum (plus sign in J).
(K–N) UW163-3 has only superior cerebellar dysplasia (arrow in L) and patchy increased T2/FLAIR (asterisks in O), but no cerebellar cysts
(K). The superior cerebellar peduncles (M) and the fourth ventricle (K and N) are normal.proposed to be the relevant gene in the MYP2 locus as-
sociated with high myopia; however, two studies evalu-
ating the association between high myopia and SNPs in
LAMA1 yielded conflicting results.27,28
In addition to identifying LAMA1mutations as the cause
of the recently described, distinctive CDC phenotype, this
work expands the CDC spectrum to include individuals
with retinal dystrophy, mild cerebellar dysplasia, and no
cysts. High myopia and large eye globes are also prevalent
features. Of note, a homozygous LAMA1 frameshift muta-
tion was identified in siblings (born to consanguineous
parents) with a phenotypic description limited to ‘‘mild in-
tellectual disability and strabismus,’’29 so it is unclear
whether these individuals have CDC or whether LAMA1
loss of function can cause isolated intellectual disability.
The combination of cerebellar vermis hypoplasia, ab-
normal superior cerebellar peduncles, and retinal dystro-
phy could result in misdiagnosis of Joubert syndrome.The AmerAlthough close examination of the retina and brain MRI
might appropriately classify most individuals, genetic
testing should be the most definitive way to separate the
disorders. On the basis of the knownmutations, we cannot
identify genotype-phenotype correlations, given that the
siblings with the mildest brain phenotype (UW163-3
and UW163-4) have a combination of a relatively early
stop-gain mutation and a frameshift mutation. Finally,
this work expands our understanding of the phenotypic
spectrum associated with lamininopathy disorders and
highlights the tissue-specific roles played by different lam-
inin-encoding genes.Supplemental Data
Supplemental Data include two figures and two tables and can be
found with this article online at http://dx.doi.org/10.1016/j.ajhg.
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Table 2. Clinical Features in Affected Individuals with LAMA1 Mutations
CA0035 UW154-3 UW162-3 UW160-3 UW160-4 UW163-3 UW163-4
Ethnicity Iranian mixed European mixed European mixed European mixed European Asian and
African
American
Asian and
African
American
Sex female female male female male female female
Age 36 months 36 months 25 months 29 years 23 years 5.5 years 4.5 years
OFC (age) 50th percentile
(12 months)
>98th percentile
(36 months)
20th percentile
(17 months)
50th percentile
(8 years)
30th percentile
(29 months)
35th percentile
(29 months)
35th percentile
(16 months)
Height or
length (age)
90th percentile
(12 months)
4th percentile
(36 months)
60th percentile
(17 months)
155 cm (adult) 168 cm (adult) 60th percentile
(25 months)
40th percentile
(16 months)
Weight
(age)
97th percentile
(12 months)
65th percentile
(36 months)
25th percentile
(17 months)
77 kg (adult) 93 kg (adult) 60th percentile
(25 months)
30th percentile
(16 months)
NDV moderate
motor and
speech delay
moderate motor
delay (no standing
or walking), mild
speech delay
motor delay
(cruising, but
no walking),
hypotonia
history of motor
delay, normal
speech, normal
IQ, college
graduate, lives
independently
history of motor
and speech delay,
normal IQ, autism
spectrum disorder
(Asperger), lives
with parents
mild motor
and speech
delay,
hypotonia
motor and
speech delay,
hypotonia
Eye
movements
strabismus,
amblyopia
strabismus,
nystagmus
strabismus,
nystagmus
strabismus,
OMA
strabismus,
amblyopia
OMA OMA, strabismus
S/P surgery,
nystagmus
Retina atrophic
appearing
thinned absent pigment lattice and
peripheral
degeneration,
macular
heterotopia,
increased
pigment
atrophic
appearing
retinal
dysfunction:
cones more
affected than
rods on ERG
chorioretinal
atrophy, macular
and peripheral
involvement,
cones worse than
rods on ERG
Acuity high myopia
(13.5)
high myopia (17) myopia high myopia
(16.5)
high myopia
(13.5)
Myopia
(3.00)
high myopia
(11.5)
CK (ref.) 177 (0–170 IU/l) 53 (26–40 IU/l) 141 (24–204 IU/l) ND ND ND ND
Other aminoaciduria,
consanguinity
one partial
seizure (on Keppra),
maternally inherited
heterozygous
800 kb deletion:
10p12.1–p12.2
mother on
Clomid, normal
SNP array
fatty liver on
ultrasound,
syndactyly in
second
and third toes
bilateral cataracts
at 22 years old,
possibly echogenic
liver on ultrasound,
syndactyly in second
and third toes
NA NA
Abbreviations are as follows: CK, creatine kinase; ERG, electroretinography; NA, not applicable; ND, not done; NDV, neurodevelopmental features; OMA, ocu-
lomotor apraxia; ref., reference; and S/P, status post.Acknowledgments
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